Home › Hidradenitis Suppurativa › NCT03146676
The Ohio State University Dermatology Biorepository
RecruitingObservational studyHealthy volunteers welcome
Who can join
All ages · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Seen by an Ohio State University (OSU) Dermatology provider on the main University Hospital campus, including the James Cancer Hospital, OSU Dermatology East, OSU Dermatology at the Ohio State Eye and Ear Institute, Martha Morehouse Medical Pavilion, and OSU Dermatology at Upper Arlington after the date of approval of this protocol * Ability to provide informed consent, or parent or legal guardian capable of providing consent for child or mentally handicapped individuals * Willingness to participate in a research study. Exclusion Criteria: * Inability to provide informed consent
About the study
This study will create and extend a source of clinical specimens for the future study of inflammatory skin disorders.
Sponsor: Ohio State University · Participants: 175 · Started: Apr 19, 2017
Contact the study team
- Alison Rocchi · Phone: 614-685-0251
- Kristina Susi · Phone: 614-814-1277
Official record on ClinicalTrials.gov — NCT03146676
Locations in the U.S.
| Ohio | OSU Dermatology West, Columbus |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.